Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · IEX Real-Time Price · USD
13.36
-0.13 (-0.96%)
At close: Jul 19, 2024, 4:00 PM
13.30
-0.06 (-0.45%)
After-hours: Jul 20, 2024, 12:57 PM EDT
Takeda Pharmaceutical Employees
Takeda Pharmaceutical Company had 49,281 employees as of March 31, 2024. The number of employees increased by 186 or 0.38% compared to the previous year.
Employees
49,281
Change (1Y)
186
Growth (1Y)
0.38%
Revenue / Employee
$571,462
Profits / Employee
$19,309
Market Cap
42.15B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 49,281 | 186 | 0.38% |
| Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
| Mar 31, 2022 | 47,347 | 248 | 0.53% |
| Mar 31, 2021 | 47,099 | -396 | -0.83% |
| Mar 31, 2020 | 47,495 | -2,083 | -4.20% |
| Mar 31, 2019 | 49,578 | 22,348 | 82.07% |
| Mar 31, 2018 | 27,230 | -2,670 | -8.93% |
| Mar 31, 2017 | 29,900 | -1,268 | -4.07% |
| Mar 31, 2016 | 31,168 | -160 | -0.51% |
| Mar 31, 2015 | 31,328 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 87,000 |
| Humana | 67,600 |
| GE HealthCare Technologies | 51,000 |
| Cencora | 46,000 |
| Haleon | 25,408 |
| Alcon | 25,315 |
| Agilent Technologies | 18,100 |
| IDEXX Laboratories | 11,000 |
TAK News
- 4 days ago - nference Establishes AI Initiative with Takeda to Advance Precision Medicine in Inflammatory Bowel Disease - Business Wire
- 26 days ago - Takeda Announces New Assignments of Directors - Business Wire
- 4 weeks ago - Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies - Business Wire
- 4 weeks ago - Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia - Business Wire
- 4 weeks ago - Takeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal Cancer - Business Wire
- 4 weeks ago - Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India - Reuters
- 4 weeks ago - Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda - PRNewsWire
- 4 weeks ago - Takeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA® in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting - Business Wire